Breast MRI as a screening tool: The appropriate role

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 4, Issue 5, 2006, Pages 523-526

  Le Petross, Huong T ^a,b  

^a University of Texas M D Anderson Cancer Center ^*

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; High risk; Magnetic resonance imaging; Screening

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; DIAGNOSTIC IMAGING; GENE MUTATION; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ULTRASOUND;

EID: 33747604375     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2006.0042     Document Type: Article

References (19)

1. Ries LAG, Eisner MP, Kosary CL, et al. SEHR cancer statistics review, 1975-2002. Bethesda: National Cancer Institute, 2004.
2. Breast Cancer Facts and Figures 2005-2006. Atlanta: American Cancer Society, 2005.
3. Verhoog LC, Brekelmans CT, Seynaeve C, et al. Survival and tumour characteristics of breast cancer patients with germline mutations of BRCA1. Lancet 1998;351:316-321.
4. Cancer Research Campaign (CRC) Genetic Epidemiology Unit, Strangeways Research Laboratory, Cambridge, U.K. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999;91:1310-1316.
5. Ford D, Easton DF, Bishop DT, et al. Risks of cancer in BRCA1-mutation carriers. The Breast Cancer Linkage Consortium. Lancet 1994;19;343:692-695.
6. Kuhl CK, Kuhn W, Schild H. Management of women at high risk for breast cancer: New imaging beyond mammography. Breast 2005;14:480-486.
7. Mitchell G, Antoniou AC, Warren R. Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res 2006;66:1866-1872.
8. Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005;103:1898-1905.
9. Morns EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. Am J Roentgenol 2003;181:519-525.
10. Lehman CD, Blume JD, Thickman D, et al. Added cancer yield ot MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 2005;92:9-15.
11. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001;19:3524-3531.
12. Stoutjesdijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mammography in women with a hereditary risk ot breast cancer. J Natl Cancer Inst 2001;18;93:1095-1102.
13. Kriege M, Cecile TM, Brekelmans MD, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351: 427-437.
14. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:1317-1325.
15. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk tor breast cancer. J Clin Oncol 2005;23: 8469-8476.
16. Liberman L. The high risk patient and magnetic resonance imaging. In: Morris EA, Liberman L, eds. Breast MRI Diagnosis and Intervention. New York: Springer, 2005:184-199.
17. Lee CH, Weinreb JC. The use of magnetic resonance imaging in breast cancer screening. J Am Coll Radiol 2004;1:176-182.
18. Morris EA. Screening for breast cancer with MRI. Semin Ultrasound, CT MR 2003;24:45-54.
19. Komenaka IK, Ditkoff BA, Joseph KA, et al. The development of interval breast malignancies in patients with BRCA mutations. Cancer 2004;100:2079-2083.